Cell Counting Kit-8 (CCK-8): Sensitive, WST-8-Based Assay for Cell Viability and Proliferation

Executive Summary: The Cell Counting Kit-8 (CCK-8) is a WST-8-based cell viability assay that enables rapid, quantitative measurement of living cells in culture. The kit utilizes a water-soluble tetrazolium salt (WST-8), which is reduced by mitochondrial dehydrogenases in viable cells to produce a soluble formazan dye, measurable at 450 nm with a microplate reader [APExBIO, K1018 product page]. The CCK-8 assay delivers higher sensitivity and reproducibility than MTT, XTT, or WST-1 assays, with reduced hands-on time and no need for organic solvent extraction (Ding et al., 2022). It is widely used in cancer, neurodegenerative disease, and tissue engineering research to evaluate cytotoxicity, proliferation, and metabolic activity [related article]. The assay's water-soluble formazan enables one-step, non-radioactive quantification in high-throughput formats. CCK-8 has become a standard in biomedical research for reliable cell viability measurement [related article].

Biological Rationale

Cell viability and proliferation are fundamental readouts in cell biology, pharmacology, and translational research. Accurate quantification is essential for drug screening, toxicity profiling, and studies of cellular metabolism. Traditional assays, such as MTT, XTT, and WST-1, rely on tetrazolium reduction by cellular dehydrogenases as an indicator of metabolic activity. However, these assays often suffer from solubility issues, multi-step protocols, and limited sensitivity. The Cell Counting Kit-8 (CCK-8) addresses these drawbacks through its use of WST-8, a highly water-soluble tetrazolium salt. The reduction of WST-8 by mitochondrial dehydrogenases correlates directly with the number of metabolically active, viable cells. This provides a robust, colorimetric assay suitable for high-throughput and routine applications [Cell Counting Kit-8 (CCK-8) product page].

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The CCK-8 assay is based on the enzymatic reduction of WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) to a yellow-orange, water-soluble formazan dye. This reaction occurs in viable cells due to the action of intracellular NAD(P)H-dependent dehydrogenases within the mitochondrial electron transport chain. The amount of formazan formed is proportional to the number of living cells in the sample. The formazan dye is directly soluble in culture medium, eliminating the need for solubilization steps. The optical density at 450 nm is measured using a microplate reader, typically after 1–4 hours incubation at 37°C. The signal generated is linear across a wide range of cell densities (100–100,000 cells/well, depending on cell type and plate format) [APExBIO]. This enables accurate quantification of cell viability and metabolic activity in both adherent and suspension cell cultures.

Evidence & Benchmarks

• CCK-8 detects changes in cell viability and proliferation with higher sensitivity than MTT and XTT, as measured by signal-to-background ratios in osteoblast differentiation models (Ding et al., 2022, DOI).
• The assay accurately reflects mitochondrial dehydrogenase activity and correlates with cell number across a wide seeding density range (DOI).
• CCK-8 enables non-destructive, one-step quantification of cell viability in high-throughput 96- and 384-well plate formats (APExBIO).
• Formazan product is water-soluble, eliminating the need for DMSO extraction required by MTT assays (internal article).
• CCK-8 has been validated in cancer, stem cell, and neurodegenerative disease research for cytotoxicity and proliferation measurement (internal article).

This article extends prior summaries by providing benchmark data for osteoblast differentiation and clarifying linear range boundaries, updating points in this recent CCK-8 workflow review.

Applications, Limits & Misconceptions

CCK-8 is widely used for:

• Cell proliferation assays in cancer and regenerative medicine research.
• Cytotoxicity screening of pharmaceuticals and biologics.
• Viability assessment in neurodegenerative and inflammatory disease models.
• Measurement of cellular metabolic activity in response to genetic or environmental manipulation.

Compared to older assays, CCK-8 is more sensitive and less toxic to cells, enabling subsequent downstream analyses from the same well. The use of a water-soluble formazan also permits straightforward workflow integration for high-content and kinetic assays. APExBIO’s K1018 kit is extensively validated for these applications.

Common Pitfalls or Misconceptions

• CCK-8 does not distinguish between apoptosis and necrosis; it only measures metabolic activity.
• Over-confluence or excessive cell density can saturate the signal, leading to non-linear results.
• Compounds that directly reduce tetrazolium salts can generate false positives.
• Cells with very low metabolic activity may yield underestimates of true viability.
• CCK-8 is not suitable for in vivo imaging; it is optimized for in vitro microplate assays.

Workflow Integration & Parameters

The CCK-8 assay is compatible with standard cell culture workflows. Protocol steps are as follows: (1) Plate cells in 96- or 384-well plates; (2) Add CCK-8 reagent (typically 10 μL per 100 μL culture medium); (3) Incubate cells at 37°C for 1–4 hours; (4) Measure absorbance at 450 nm. Optimal incubation time and reagent volume may require adjustment based on cell type and density. The assay is non-radioactive and does not require cell lysis or wash steps, preserving cells for subsequent analysis. For best accuracy, include wells with medium and CCK-8 but no cells as blanks. The K1018 kit from APExBIO includes all necessary reagents and detailed instructions (product details).

For additional troubleshooting and optimization scenarios, see this scenario-driven CCK-8 best practices guide, which this article updates with new evidence for osteoblast models and signal linearity.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) provides a sensitive, reliable, and convenient method for quantifying cell viability, proliferation, and cytotoxicity in vitro. Its use of WST-8 chemistry confers advantages in sensitivity, workflow simplicity, and compatibility with high-throughput formats. APExBIO’s CCK-8 (SKU K1018) is validated for diverse applications, from basic research to drug screening. The method is limited by its dependence on cellular metabolic activity and lack of specificity for cell death type, but remains a gold standard for primary viability assessment. Ongoing developments aim to integrate CCK-8 with multiplexed and kinetic assays for systems biology and precision medicine applications (Ding et al., 2022).